Women's Health

The women’s health channel includes news, videos, podcasts and other content related to technology used to detect and treat breast cancer and cervical cancer, including mammography, breast magnetic resonance imaging (MRI), automated breast ultrasound (ABUS), breast ultrasound, breast biopsy and breast radiation therapy.

Before TIL therapy, a woman with breast cancer had metastatic lesions in her chest wall (top, left) and liver (bottom, left). After receiving the immunotherapy, her tumors shrank completely, and recent scans (right) show that she remains cancer free more than five years later.National Cancer Institute

News | Breast Imaging

NIH Study Advances Personalized Immunotherapy for Metastatic Breast Cancer

February 1, 2022 — An experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could ...

February 01, 2022

The Global Mammography Devices Market stood at USD 2744.07 million in 2020 and is expected to grow at a steady CAGR of 5.78% during the forecast period.

News | Breast Imaging

Insights on the Mammography Devices Global Market to 2026

January 31, 2022 — The Global Mammography Devices Market stood at USD 2744.07 million in 2020 and is expected to grow at ...

January 31, 2022

The world market for breast imaging equipment is forecast to reach almost $1.3 billion by 2024, and the breast imaging artificial intelligence (AI) market is forecast to reach $205 million, according to a new report from Signify Research.

Feature | Breast Imaging | By Bhvita Jani

Global Drivers of the Breast Imaging Market

The rising global incidence rates of breast cancer, coupled with the severe backlog of women requiring breast cancer ...

January 20, 2022

Sponsored Content

LG-sponsored webinar takes place March 23 at 2 p.m. ET

Webinar | Mammography

WEBINAR: Advanced Diagnostic Technology for Accurate Imaging

The COVID-19 pandemic had a huge impact on the radiology community. Hospitals, doctors’ offices and clinics found ...

March 03, 2022

Today, as part of the U.S. Food and Drug Administration’s continued commitment to protect and promote the health of all women, the Center for Devices and Radiological Health (CDRH) is sharing its Health of Women Program Strategic Plan. CDRH initially issued a proposed strategic plan in September 2019 and has considered public feedback to inform this strategic plan, which lays out the framework to further the FDA’s mission by protecting and promoting the health of women, strengthening regulatory science, and

News | Women's Health

FDA Releases CDRH Health of Women Strategic Plan to Better Inform Medical Device Research and Regulation

January 18, 2022 — The following statement was issued today by the U.S. Food and Drug Administration (FDA), and is ...

January 18, 2022

UE LifeSciences has entered into a definitive distribution agreement with Siemens Healthineers, adding its flagship device iBreastExam to Siemens’ 360-degree breast care product portfolio for the U.S. market.

News | Breast Imaging

UE LifeSciences and Siemens Healthineers Launch iBreastExam in the U.S.

January 18, 2022 — UE LifeSciences has entered into a definitive distribution agreement with Siemens Healthineers ...

January 18, 2022

57-Year-Old Woman Presented for Screening Mammography: Digital, A, and tomosynthesis, B, craniocaudal images showed 1.8 cm asymmetry (arrows) lateral left breast categorized as BI-RADS 0. C, Ultrasound left breast evaluation revealed normal fibroglandular tissue (arrow) believed to correlate with mammographic finding. D, Asymmetry effaced on rolled lateral craniocaudal imaging. Metallic BB marker noted at 12 o’clock position, anterior depth. Final assessment BI-RADS 1. Image courtesy of ARRS

News | Ultrasound Women's Health

Recalled Noncalcified Lesions: Ultrasound vs. Ultrasound Plus Mammography

January 17, 2022 — According to an article in ARRS’ American Journal of Roentgenology (AJR), radiologists should ...

January 17, 2022

Sponsored Content

Videos | Artificial Intelligence

VIDEO: Integrating Artificial Intelligence Into Radiologists Workflow

Artificial Intelligence (AI) is becoming more common place in radiology practices, and emerging technologies are ...

November 11, 2020

Most AI for spotting pre-cancerous lesions in mammography scans don’t reveal any of their decision-making process (top). If they do, it’s often a saliency map (middle) that only tells doctors where they’re looking. A new AI platform (bottom) not only tells doctors where it’s looking, but which past experiences its using to draw its conclusions.

News | Mammography

The First AI Breast Cancer Sleuth That Shows Its Work

January 14, 2022 — Computer engineers and radiologists at Duke University have developed an artificial intelligence ...

January 14, 2022

Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare, today announced a partnership to market Lunit AI software, making it readily available to its North American customer base.

News | Mammography

Infinitt announces Partnership with Lunit

January 13, 2022 — Infinitt North America, an award-winning developer of enterprise imaging solutions for healthcare ...

January 13, 2022

Less-experienced radiologists are more likely to recommend additional imaging for women undergoing breast cancer screening when they read digital breast tomosynthesis (DBT) images later in the day, according to a new study in Radiology.

News | Breast Imaging

Radiologist Fatigue, Experience Affect Breast Imaging Call Backs

January 11, 2022 — Less-experienced radiologists are more likely to recommend additional imaging for women undergoing ...

January 11, 2022

Sponsored Content

Table 1. Compared to 2-D mammography, which yields four images per patient, digital breast tomosynthesis (DBT), or 3-D mammography, produces hundreds of images per patient. While this provides more information for clinicians, the exponential increase in data can result in reader fatigue and burnout, which may ultimately affect patient care.

Case Study | Artificial Intelligence

From Surviving to Thriving: How Regional Medical Imaging Enhanced Productivity

As the largest independent imaging group in Michigan with 10 locations across the state, Regional Medical Imaging (RMI) ...

April 09, 2020

Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak report on industry leaders in diagnostic imaging equipment in the United States.

News | Radiation Oncology

Varian and Siemens Healthineers Recognized in Survey of U.S. Radiation Oncology and Diagnostic Imaging Professionals

January 7, 2022 — Varian and parent company Siemens Healthineers have been recognized in the annual IMV ServiceTrak ...

January 07, 2022

The AI software is integrated into Gestalt Diagnostics's PathFlow platform for streamlined access and workflow for BioReference's pathologists and external pathology customers. This makes BreastIHC the first AI-based product in pathology to be used in routine clinical practice in the United States.

News | Digital Pathology

Gestalt Diagnostics and MindPeak Provide the First Artificial Intelligence Based Diagnostics Solution Used in Clinical Routine Pathology in the USA

January 5, 2022 — Hamburg, Germany, based Mindpeak and Spokane, Wash., based Gestalt Diagnostics have achieved a major ...

January 05, 2022

Videos | Breast Imaging

VIDEO: Mammography Trends and Advances at RSNA 2021

Stamatia Destounis, M.D., FACR, chief of the American College of Radiology (ACR) Breast Commission, managing partner ...

December 13, 2021

Sponsored Content

Figure 1. R MLO view from four different years. The skin mole is marked with a circular skin marker (TomoSPOT REF# 782, Beekley Medical) on the far-left image. These images demonstrate the potential for significant variability in location of the skin lesion due to movability of the skin during positioning.

Case Study | Breast Imaging

Use of Mole Markers in DBT Improves Clinical Workflow and Patient Safety

Christina Jacobs, M.D., Director of Breast Imaging (Bronson Health System) is always looking for ways to work more ...

April 09, 2020

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new and real-world research demonstrating the value of ProFound AI for Digital Breast Tomosynthesis (DBT) was highlighted at the 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), November 28 – December 2.

News | Breast Imaging

iCAD Announced Compelling New and Real-World Data Demonstrating the Value of ProFound AI at RSNA21

December 10, 2021 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy ...

December 10, 2021

A Michigan Tech-developed machine learning model uses probability to more accurately classify breast cancer shown in histopathology images and evaluate the uncertainty of its predictions.

News | Breast Imaging

Machine Learning Reduces Uncertainty in Breast Cancer Diagnoses

December 8, 2021 — A Michigan Tech-developed machine learning model uses probability to more accurately classify breast ...

December 08, 2021

Figure 1. Left image shows breast MRI in 41-year-old patient without IUD. Right image shows increased parenchymal enhancement in the same patient 27 months after IUD placement.

Feature | Radiology Imaging | By Melinda Taschetta-Millane

Top 10: Most Read Radiology Technology Content in November 2021

December 8, 2021 — Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of November ...

December 08, 2021

IceCure Medical Ltd., developer of minimally-invasive cryoablation technology, the ProSense System, that destroys tumors by freezing as an alternative to surgical tumor removal, announced that interim data from the ICE3 Clinical Trial on cryoablation of small, low-risk breast cancer was featured by Co-Primary Investigator Kenneth Tomkovich, M.D., at RSNA 2021.

News | Clinical Trials

IceCure Medical's Interim Results of the ICE3 Clinical Trial for Early-Stage Breast Cancer Cryoablation featured at RSNA 2021

December 7, 2021 — IceCure Medical Ltd., developer of minimally-invasive cryoablation technology, the ProSense System ...

December 07, 2021

Stratified by race and ethnicity, expressed as percentages of corresponding mean volume in 2018–2019. Graph courtesy of the American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | Breast Imaging

Racial Disparities and Facility Access in Mammography Recovery After COVID-19 Closures

December 7, 2021 — According to an open-access article in ARRS’ American Journal of Roentgenology (AJR), screening ...

December 07, 2021

iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its Board of Directors appointed Stacey Stevens as iCAD’s President and Chief Executive Officer (CEO), effective March 1, 2022.

News | Radiology Business

iCAD Appoints Stacey Stevens as President and CEO

December 6, 2021 — iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy ...

December 06, 2021

Gallery | RSNA | Melinda Taschetta-Millane and By Dave Fornell

Photo Gallery of Radiology Technology at RSNA 2021

This gallery includes photos of medical imaging technologies from across the expo floor at the Radiological Society of ...

December 02, 2021

News | Artificial Intelligence

Lunit to Participate in RSNA 2021, Presenting Its New AI Solutions for Digital Breast Tomosynthesis and Chest CT

November 28, 2021 — Lunit, a medical AI provider, is returning to the 107th Radiological Society of North America (RSNA) ...

November 28, 2021